- Home
- MPU vs OSRH Comparison
MPU vs OSRH Comparison
Compare MPU & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MPU | OSRH |
|---|---|---|
| Founded | 1989 | N/A |
| Country | Singapore | United States |
| Employees | N/A | 22 |
| Industry | Transportation Services | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.3M | 17.9M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | MPU | OSRH |
|---|---|---|
| Price | $0.25 | $0.42 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 213.0K | ★ 538.4K |
| Earning Date | 04-16-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $9.30 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.21 | $0.30 |
| 52 Week High | $4.44 | $1.24 |
Technical Indicators
Market Signals| Indicator | MPU | OSRH |
|---|---|---|
| Relative Strength Index (RSI) | 35.61 | 60.62 |
| Support Level | $0.21 | $0.39 |
| Resistance Level | $0.32 | $0.45 |
| Average True Range (ATR) | 0.03 | 0.03 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 20.53 | 93.17 |
Price Performance
Historical ComparisonAbout MPU Mega Matrix Corp.
Mega Matrix Inc is a holding company that offers investors an opportunity to participate in the growth of stablecoins, one of the fastest-evolving sectors in digital assets. The company generated revenue from the Membership and top-up streaming services revenue, Online advertising services, and Content licensing. Geographically, the company operates in the United States and Canada, Asia Pacific, Europe middle east and Africa, and Latin America.
About OSRH OSR Holdings Inc.
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea. The company's pipeline products include: Vaximm, Darnatein, Woori IO, and RMC.